Viking Therapeutics(VKTX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Conference call scheduled for 4:30 p.m. ET today SAN DIEGO, July 24, 2024 -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter and six months ended June 30, 2024, and provided an update on its clinical pipeline and other corporate developments. Highlights from the Quarter Ended June 30, 2024, and Other Rec ...